PeptideLeads Launches $50 Per Patient Lead Service for Peptide Therapy Clinics

HOUSTON - EntSun -- Peptide therapy clinics across the United States now have a new option for filling their patient pipeline without the financial risk that comes with traditional marketing agencies.

PeptideLeads, founded by Tamerlan Musayev, officially launched its performance-based patient generation service in early 2026. The company works exclusively with peptide therapy clinics and operates on a simple model — clinics pay $50 for each qualified patient lead delivered to their practice. There are no retainer fees, no setup costs, and no long-term contracts.

What makes the model different from most healthcare marketing agencies is that PeptideLeads covers all advertising costs upfront. The clinic never pays for ad spend. They only pay when a real, verified patient lead lands in their inbox.

"Most clinics I talk to are tired of paying agencies three to five thousand dollars a month and having no idea what they're getting for it," said Musayev. "We wanted to build something where the clinic only pays for actual results. If we don't deliver, they don't pay. That's it."

More on EntSun News

• New and Returning Events for 2026 Season
• Spring Into Your New Home at Heritage at South Brunswick
• UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
• HarryPotterObamaSonic10Inu (Ticker: BITCOIN) Is the Best Cryptocurrency in Global History
• Poland Spring Announced as Official Sponsor For NKENNE's Homecoming event at Rose NYC

Each lead is verified before delivery with a confirmed name, phone number, and email from a patient who has expressed interest in peptide therapy. PeptideLeads also limits its partnerships to one clinic per zip code, which means clinics are not competing with a neighboring practice for the same leads.

The company currently generates leads through targeted advertising campaigns on social media platforms, reaching patients interested in treatments including BPC-157, CJC-1295, Ipamorelin, Sermorelin, Thymosin Alpha-1, and Semaglutide among others.

PeptideLeads is based in Katy, Texas and works with clinics nationwide. Interested clinic owners can book a free strategy call at peptideleads.com.

For more information visit https://www.peptideleads.com or contact tamer@peptideleads.com.